327 related articles for article (PubMed ID: 24631699)
1. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
[TBL] [Abstract][Full Text] [Related]
2. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.
Boilesen AE; Bisgaard ML; Bernstein I
Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272
[TBL] [Abstract][Full Text] [Related]
3. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
4. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
[TBL] [Abstract][Full Text] [Related]
5. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
6. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
Brown GJ; St John DJ; Macrae FA; Aittomäki K
Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families.
Auranen A; Joutsiniemi T
Acta Obstet Gynecol Scand; 2011 May; 90(5):437-44. PubMed ID: 21306348
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
11. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
[TBL] [Abstract][Full Text] [Related]
12. Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature.
Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
[TBL] [Abstract][Full Text] [Related]
13. [Lynch syndrome and gynaecologic's cancer: follow-up recommendations].
Magri K; Millon G
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):68-71. PubMed ID: 17293255
[TBL] [Abstract][Full Text] [Related]
14. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
15. Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.
Taylor N; Mutch DG
Oncology (Williston Park); 2006 Jan; 20(1):85-94; discussion 94-6, 100. PubMed ID: 16572595
[TBL] [Abstract][Full Text] [Related]
16. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
[TBL] [Abstract][Full Text] [Related]
19. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.
Stuckless S; Green J; Dawson L; Barrett B; Woods MO; Dicks E; Parfrey PS
Clin Genet; 2013 Apr; 83(4):359-64. PubMed ID: 22775459
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome.
Renkonen-Sinisalo L; Bützow R; Leminen A; Lehtovirta P; Mecklin JP; Järvinen HJ
Int J Cancer; 2007 Feb; 120(4):821-4. PubMed ID: 17096354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
